{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifhtbuivkabsbhpuca6wllh2r3b4nozehbqp4t2s4bn76dzdxffmm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjj4kmsfz562"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiazkds6tgxasugfyevkk4s52epigdnlof4f7joyjgry53qjulq2bi"
    },
    "mimeType": "image/jpeg",
    "size": 36545
  },
  "path": "/2026/04/14/ben-sasse-revolution-medicines-daraxonrasib-clinical-trial/?utm_campaign=rss",
  "publishedAt": "2026-04-14T08:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Health",
    "Pharma",
    "Politics",
    "biotech",
    "Cancer",
    "Congress",
    "pharma"
  ],
  "textContent": "Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but promising new drug for pancreatic cancer.",
  "title": "For Ben Sasse, Revolution Medicines’ pancreatic cancer trial felt like his best, only option",
  "updatedAt": "2026-04-14T11:19:44.000Z"
}